"Achieving 'evidence-based' status is a watershed moment for 3Strands Global Foundation, as it validates our decade-long commitment to rigorous, data-driven prevention," said Ashlie Bryant, CEO and Co ...
The 2025 Impact Report makes clear that Oshi's results are not limited to a single patient segment, condition, acuity, or location. As the model has expanded nationwide, outcomes have remained ...
Researchers at the University of Liège have identified a key genetic regulator that enables macrophages to reach full maturity and preserve the health of our organs. The MafB factor, a veritable ...
The addition of PacBio to the iHope network will further expand diagnostic access worldwide DAMASCUS, MD, UNITED ...
NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal ...
Q4 2025 Earnings Call February 26, 2026 9:00 AM ESTCompany ParticipantsMichael Castagna - CEO & DirectorChristopher ...
WCAX on MSN
Surgeon general nominee faces sharp questions about vaccines, birth control and qualifications
“I have very serious questions about the ability of Dr. Means to be the kind of surgeon general this country needs,” Vermont independent Sen. Bernie Sanders said.
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...
Drilling on Exploration Target 819,000 to 1,019,000 oz Au Exploration Target grading between 0.48 g/t Au and 0.63 g/t Au in ...
Significant year-over-year Q4 declines in glucagon (45% drop to $14.1 million) and epinephrine (9% drop to $17.1 million), attributed to "increased competition" and market shift to ready-to-use ...
Legacy Gold Mines Ltd. (TSXV: LEGY) (the “Company” or “Legacy Gold”) has laid out its 2026 surface exploration drill program of roughly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results